leisure time -WSS

leisure time

author：Wikipedia 2025-08-12 06:45:01 - browse：356

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Roche drug slashes death risk in early

focus

WSS

STAT Readout Newsletter: Biotech news today

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Weight bias in eating disorder treatment complicated by new weight loss drugs

STAT's guide to the next generation of CAR

In areas with more Black doctors, Black people live longer

Cloning humans is technically possible. It's curious no one has tried

explore

leisure time

entertainment

Medical records are filled with copy

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

State Dept. review finds Biden bears some blame for Afghanistan failures

Questions loom on AstraZeneca cancer drug as safety concerns ebb

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The science behind Janet Jackson's pregnancy at 49

Drug repurposing or repositioning? The language matters

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Activists slam private health insurers over coverage restrictions

What would happen to your eyes if you looked at the solar eclipse?

hotspot

Why drug prescriptions should include diagnoses

With FDA staff opposed to Sarepta therapy, top official intervened

Ask STAT: What do you want to know about ChatGPT in medicine?

Cassava Sciences’ Alzheimer’s clinical trials should be halted

CDC concerned about possible undetected monkeypox spread in U.K.

Questions loom on AstraZeneca cancer drug as safety concerns ebb

entertainment

focus

focus

hotspot